Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer. - Wikidata - wikimedia - TriplyDB

Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer.

Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer.

http://www.wikidata.org/entity/Q43873674

about

Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potential Reconstruction of temporal activity of microRNAs from gene expression data in breast cancer cell line.Computational prediction of disease microRNAs in domestic animals Circulating miR-148b and miR-133a as biomarkers for breast cancer detection.Cell-free nucleic acids as non-invasive biomarkers of gynecological cancers, ovarian, endometrial and obstetric disorders and fetal aneuploidy.Critical analysis of the potential for microRNA biomarkers in breast cancer management.Assay reproducibility in clinical studies of plasma miRNA The expression and clinical significance of serum miR-205 for breast cancer and its role in detection of human cancers.Circulating cell-free miRNAs as biomarker for triple-negative breast cancer Noncoding RNAs in breast cancer.Extracellular circulating viral microRNAs: current knowledge and perspectives Assessing Clinical Significance of Serum CA15-3 and Carcinoembryonic Antigen (CEA) Levels in Breast Cancer Patients: A Meta-Analysis A novel panel of serum miR-21/miR-155/miR-365 as a potential diagnostic biomarker for breast cancer.microRNAs: a new class of breast cancer biomarkers.The validity of circulating microRNAs in oncology: five years of challenges and contradictions.miRNA-221 of exosomes originating from bone marrow mesenchymal stem cells promotes oncogenic activity in gastric cancer Diagnostic significance of circulating multiple miRNAs in breast cancer: a systematic review and meta-analysis.Overexpression of microRNA-30a inhibits hepatitis B virus X protein-induced autophagosome formation in hepatic cells.The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs.Circulating miRNAs in sepsis-A network under attack: An in-silico prediction of the potential existence of miRNA sponges in sepsis.miR-205 and miR-200c: Predictive Micro RNAs for Lymph Node Metastasis in Triple Negative Breast Cancer.Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures.The roles of ncRNAs in the diagnosis, prognosis and clinicopathological features of breast cancer: a systematic review and meta-analysis.Diagnostic value of circulating microRNAs as biomarkers for breast cancer: a meta-analysis study.Dysregulated expression of Dicer in invasive ductal breast carcinoma.

P2860

Q26782613-DF2F9E68-EAA4-4991-9C3B-8AF7CCCCCCE0 Q31036763-0FBA2943-E17E-445A-9CA0-6BE057E593EA Q33881021-8B8F16C0-715E-4F7B-980E-3CEFBF003812 Q34221705-476D2BCB-F8C9-41E2-8396-BD8D8D1FAFF3 Q34426839-5E9331C3-4A8E-4B5B-8D6D-48C799C79A81 Q35137273-4DA52EBF-226A-4C9E-81ED-4221BFA1AB56 Q35325816-FBE15C96-4B0B-4292-B1A4-8ED212CB8372 Q35482100-6A7FCF44-9E85-45D2-BFF5-4AFC1C938D2D Q36285931-89211010-566A-48AC-BF3B-ED64D63B7814 Q36935047-CC3EE9EA-D64C-438F-B337-0D7A12F186C8 Q36948792-771FFCDE-DEFA-4088-AE7C-5B8667D775DD Q37255288-135AD3E4-AF4C-467E-AD74-6093246CE39E Q37641977-4846869B-4E80-487D-BB96-D5CD1F2C8BC4 Q38197675-D9A31330-7B2B-4899-B386-4A7392218EE0 Q38198366-D78675E4-AAF9-49EC-B424-D385DD878060 Q38634707-7276F744-7602-485B-AF9E-9B9902540030 Q38845874-C2EDD1D3-D689-4702-9662-4CED55500F72 Q38916504-BC2D25E3-E39B-4A89-8C07-50B76DAE638B Q39097267-A468C57C-FF10-4B3E-B60A-372892137649 Q40078180-A97DB2D3-3CB8-4298-84D3-3FC2B37538DB Q41986222-3DDF0093-E7DB-48B9-84B8-CE85EA866780 Q42917130-F2AB5AE3-02CF-43FB-BA13-EADFB96ADCED Q47104938-A42D783C-BB44-4481-9C82-6763134ADD5A Q53420685-762AF6E4-0DD9-40A3-AE92-3F75834AE902 Q53466891-58E2CD44-638E-4256-B7B3-65C687721871

P2860

Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer.

http://www.wikidata.org/entity/Q43873674

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer.

@en

Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer.

@nl

type

label

Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer.

@en

Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer.

@nl

prefLabel

Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer.

@en

Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer.

@nl

P1433

Q43873674-1AE1F084-104F-4DFF-9DD6-BEB88B9F7638

P1476

Q43873674-8D85B7E5-6B56-4F9D-BB20-B1ED679690F8

P2093

Q43873674-009D97EE-2621-42A1-9D27-B654BD67B192

Q43873674-2D7B6436-38B7-4668-95A1-D72550410433

Q43873674-42BA250C-B1A1-4355-9F13-3FDF07EB1588

Q43873674-66489C03-0188-44A6-B788-5D3832E1F35B

Q43873674-78F45B4B-726C-4986-8F77-B039A6D0F670

Q43873674-890D3B17-AF85-4C4D-A5D6-15719C22448D

Q43873674-BC43493A-4ACB-479A-9E1B-8EE1B7238F41

Q43873674-E58DE0CD-C35C-4E73-BFDF-9980FA2114F4

P2860

Q43873674-02540FB4-BC4E-4C60-B557-3FFB9BC7B040

Q43873674-055AE844-9776-4BC0-8BD8-3B9AFD5B9FD6

Q43873674-0CA23853-B25A-4C0F-945C-6F1897912167

Q43873674-0EFBF1FA-38A8-4C49-9768-6CC8273A7681

Q43873674-14C32877-5729-4A40-8C93-5A5AD64EB855

Q43873674-15677DE7-EBCA-48FE-B07E-DD7599DFB100

Q43873674-223E7850-3540-4284-9C4E-9823E1C53E32

Q43873674-3A2321E8-A78D-4B8D-9D55-FFD91C95CD4E

Q43873674-411B6A66-1F1C-4FED-8097-F47E53B2F756

Q43873674-4FD7B9A8-20D1-4229-9F7F-BB0B8B367DAE

P2888

Q43873674-A8F85902-545C-4066-8C6C-2F30DF6035A0

P304

Q43873674-9C0A2B26-59D5-49AC-9507-2C71FC9ECAD4

P31

Q43873674-D21C7B20-4F0C-415D-9A0E-481CA25D14FB

P356

Q43873674-7CC4CF90-E57F-4C67-ABC8-2080410A457C

P433

Q43873674-BA8FF995-DF70-47B6-97A4-7161347A1E01

P478

Q43873674-A57CF5EC-00F1-46F2-B1BE-683E4E8D39B5

P577

Q43873674-6A38E7D3-8AE3-4E49-8C6A-86C8914302E8

P6179

Q43873674-8F9B25E2-2054-4458-BA42-C23C17C8FFC4

P698

Q43873674-23314DCF-E9C5-4C62-B332-D86B06488C6A

P356

S12032-013-0477-Z

P1433

Medical Oncology

P1476

Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer.

@en

P2093

Du-ping Huang

http://www.w3.org/2001/XMLSchema#string

En-dong Chen

http://www.w3.org/2001/XMLSchema#string

Guan-li Huang

http://www.w3.org/2001/XMLSchema#string

Rui-chao Zeng

http://www.w3.org/2001/XMLSchema#string

Wei Zhang

http://www.w3.org/2001/XMLSchema#string

Xiao-hua Zhang

http://www.w3.org/2001/XMLSchema#string

Xing-qiang Yan

http://www.w3.org/2001/XMLSchema#string

Zhi-qiang Ye

http://www.w3.org/2001/XMLSchema#string

P2860

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

Circulating microRNAs as stable blood-based markers for cancer detection.

Real-time expression profiling of microRNA precursors in human cancer cell lines.

MicroRNA gene expression deregulation in human breast cancer

Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement

Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer

Circulating microRNAs in breast cancer and healthy subjects

Triple-negative breast cancer: clinical features and patterns of recurrence.

Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms.

P2888

s12032-013-0477-z

P304

477

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12032-013-0477-Z

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1035086990

http://www.w3.org/2001/XMLSchema#string

P698

23389917

http://www.w3.org/2001/XMLSchema#string